United Therapeutics Corporation
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2008 | -8.9% | -8.9% | — |
| FY2009 | 3.0% | 3.0% | 1.9% |
| FY2010 | 12.0% | 12.0% | 7.4% |
| FY2011 | 23.0% | 23.0% | 14.4% |
| FY2012 | 28.1% | 28.1% | 18.7% |
| FY2013 | 13.9% | 13.9% | 8.4% |
| FY2014 | 27.4% | 27.4% | 18.0% |
| FY2015 | 41.0% | 41.0% | 29.8% |
| FY2016 | 38.6% | 38.6% | 30.7% |
| FY2017 | 19.9% | 19.9% | 14.5% |
| FY2018 | 21.1% | 21.1% | 17.3% |
| FY2019 | -3.8% | -3.8% | -2.7% |
| FY2020 | 15.2% | 15.2% | 11.2% |
| FY2021 | 12.0% | 12.0% | 9.2% |
| FY2022 | 15.2% | 15.2% | 12.0% |
| FY2023 | 16.5% | 16.5% | 13.7% |
| FY2024 | 18.5% | 18.5% | 16.2% |
| FY2025 | 18.8% | 18.8% | 16.9% |